Fukuoka, Japan

Masaki Nagahama

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Fukuoka, JP (2017 - 2023)
  • Chiyoda-ku, JP (2023 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Masaki Nagahama: Innovator in Pharmaceutical Chemistry

Introduction

Masaki Nagahama, a prominent inventor based in Fukuoka, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a total of 12 patents to his name, he has focused on developing methods and compounds that enhance the efficacy and purity of pharmaceutical products.

Latest Patents

Among his latest innovations, Masaki Nagahama has developed a method for producing high purity 2-naphthylacetonitrile. This compound is not only useful as a starting material or intermediate in the synthesis of various pharmaceutical and agricultural chemicals but is also characterized by its high purity, exhibiting an HPLC purity of not less than 95%. The production method ensures that naphthalene compounds are minimized to a predetermined area percentage or below.

Another significant invention by Nagahama is a novel process for producing rosuvastatin calcium and its intermediates. This new method promises to efficiently manufacture rosuvastatin calcium at an industrial scale without the requirement of extremely low temperature reactions or special asymmetric catalysts, ensuring high purity and cost-effectiveness.

Career Highlights

Masaki Nagahama is currently employed at Api Corporation, where he continues his groundbreaking work in pharmaceutical research and development. His dedication and innovative approach have earned him recognition within the industry.

Collaborations

Throughout his career, Nagahama has collaborated with notable colleagues, including Naoyuki Watanabe and Daiki Okado. Together, they have worked on various projects that contribute to advancements in chemical synthesis and pharmaceutical innovation.

Conclusion

Masaki Nagahama's work and patents represent the forefront of innovation in the pharmaceutical industry. His commitment to enhancing product purity and developing efficient production methods positions him as a valuable inventor whose contributions will likely impact future pharmaceutical developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…